Preferences of Dutch Parents and Expectant Parents for Respiratory Syncytial Virus Prevention Strategies: A Discrete Choice Experiment
The results suggest that most Dutch parents and expectant parents would prefer a maternal vaccine to an infant mAb injection to immunise their infants against an RSV-like virus. An NIP that incorporates both strategies may enhance uptake and protect the most infants. However, as the attributes were not exhaustively or explicitly presented in the context of RSV prevention, the results may not be completely transferable.
Authors
- Annefleur C. Langedijk (ORCID: https://orcid.org/0000-0003-1190-1894)
- Diana Mendes (ORCID: https://orcid.org/0000-0002-1672-4906)
- Marlies A. van Houten (ORCID: https://orcid.org/0000-0002-5942-8082)
- M. Claire Verhage
- Lisanne van Leeuwen
- Lisette Harteveld
- Lucy Smit
- Joke H. de Boer
- Floris van den Dungen
- Elise Kocks
Institutions
- Pfizer (United Kingdom) (GB)
- Islamic University of Rotterdam (NL)
- Spaarne Ziekenhuis (NL)
- Pfizer (Netherlands) (NL)
- GGD Amsterdam (NL)
- Spaarne Gasthuis (NL)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1007/s40121-025-01214-2
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71